nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—Lisinopril—systemic scleroderma	0.0799	0.211	CbGbCtD
Promethazine—CYP2C9—Leflunomide—systemic scleroderma	0.0785	0.208	CbGbCtD
Promethazine—ABCB1—Captopril—systemic scleroderma	0.0598	0.158	CbGbCtD
Promethazine—CYP2D6—Captopril—systemic scleroderma	0.0563	0.149	CbGbCtD
Promethazine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0471	0.125	CbGbCtD
Promethazine—ABCB1—Prednisone—systemic scleroderma	0.0376	0.0995	CbGbCtD
Promethazine—CYP2C9—cardial valve—systemic scleroderma	0.0298	0.188	CbGeAlD
Promethazine—ABCB1—Methotrexate—systemic scleroderma	0.0189	0.0499	CbGbCtD
Promethazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.014	0.0884	CbGeAlD
Promethazine—HTR2A—pulmonary artery—systemic scleroderma	0.00994	0.0626	CbGeAlD
Promethazine—CALM2—artery—systemic scleroderma	0.00608	0.0383	CbGeAlD
Promethazine—CALM1—artery—systemic scleroderma	0.00605	0.0381	CbGeAlD
Promethazine—CALM2—endothelium—systemic scleroderma	0.00513	0.0323	CbGeAlD
Promethazine—CALM1—endothelium—systemic scleroderma	0.00511	0.0322	CbGeAlD
Promethazine—CALM2—blood vessel—systemic scleroderma	0.00473	0.0298	CbGeAlD
Promethazine—CALM1—blood vessel—systemic scleroderma	0.00471	0.0297	CbGeAlD
Promethazine—CHRM5—skin of body—systemic scleroderma	0.004	0.0252	CbGeAlD
Promethazine—HTR2A—artery—systemic scleroderma	0.00369	0.0232	CbGeAlD
Promethazine—HTR2A—endothelium—systemic scleroderma	0.00311	0.0196	CbGeAlD
Promethazine—HTR2A—blood vessel—systemic scleroderma	0.00287	0.0181	CbGeAlD
Promethazine—CALM3—smooth muscle tissue—systemic scleroderma	0.00283	0.0178	CbGeAlD
Promethazine—CALM2—connective tissue—systemic scleroderma	0.00243	0.0153	CbGeAlD
Promethazine—CALM1—connective tissue—systemic scleroderma	0.00242	0.0152	CbGeAlD
Promethazine—CHRM3—smooth muscle tissue—systemic scleroderma	0.00227	0.0143	CbGeAlD
Promethazine—CALM2—smooth muscle tissue—systemic scleroderma	0.00222	0.014	CbGeAlD
Promethazine—CALM1—smooth muscle tissue—systemic scleroderma	0.00221	0.0139	CbGeAlD
Promethazine—CALM2—skin of body—systemic scleroderma	0.00219	0.0138	CbGeAlD
Promethazine—CALM1—skin of body—systemic scleroderma	0.00218	0.0137	CbGeAlD
Promethazine—CALM3—tendon—systemic scleroderma	0.00212	0.0134	CbGeAlD
Promethazine—ABCB1—blood vessel—systemic scleroderma	0.00188	0.0119	CbGeAlD
Promethazine—CALM3—lung—systemic scleroderma	0.00186	0.0117	CbGeAlD
Promethazine—CHRM3—digestive system—systemic scleroderma	0.00179	0.0113	CbGeAlD
Promethazine—HRH1—connective tissue—systemic scleroderma	0.00176	0.0111	CbGeAlD
Promethazine—CALM2—digestive system—systemic scleroderma	0.00175	0.011	CbGeAlD
Promethazine—CALM1—digestive system—systemic scleroderma	0.00175	0.011	CbGeAlD
Promethazine—CHRM1—lung—systemic scleroderma	0.00167	0.0105	CbGeAlD
Promethazine—CALM2—tendon—systemic scleroderma	0.00167	0.0105	CbGeAlD
Promethazine—CALM1—tendon—systemic scleroderma	0.00166	0.0105	CbGeAlD
Promethazine—CYP2B6—skin of body—systemic scleroderma	0.00163	0.0103	CbGeAlD
Promethazine—HRH1—smooth muscle tissue—systemic scleroderma	0.00161	0.0102	CbGeAlD
Promethazine—HTR2A—connective tissue—systemic scleroderma	0.00147	0.00927	CbGeAlD
Promethazine—CALM2—lung—systemic scleroderma	0.00146	0.00922	CbGeAlD
Promethazine—CALM1—lung—systemic scleroderma	0.00146	0.00918	CbGeAlD
Promethazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00135	0.00848	CbGeAlD
Promethazine—DRD2—lung—systemic scleroderma	0.00135	0.00848	CbGeAlD
Promethazine—CYP2B6—digestive system—systemic scleroderma	0.0013	0.00821	CbGeAlD
Promethazine—CYP2C9—digestive system—systemic scleroderma	0.00129	0.00813	CbGeAlD
Promethazine—HRH1—digestive system—systemic scleroderma	0.00127	0.00802	CbGeAlD
Promethazine—HRH1—tendon—systemic scleroderma	0.00121	0.00763	CbGeAlD
Promethazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00116	0.00291	CcSEcCtD
Promethazine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00115	0.0029	CcSEcCtD
Promethazine—Dry mouth—Captopril—systemic scleroderma	0.00114	0.00287	CcSEcCtD
Promethazine—Bradycardia—Lisinopril—systemic scleroderma	0.00113	0.00285	CcSEcCtD
Promethazine—Euphoric mood—Prednisone—systemic scleroderma	0.00113	0.00285	CcSEcCtD
Promethazine—Confusional state—Captopril—systemic scleroderma	0.00113	0.00284	CcSEcCtD
Promethazine—Dyspepsia—Mometasone—systemic scleroderma	0.00112	0.00282	CcSEcCtD
Promethazine—Anaphylactic shock—Captopril—systemic scleroderma	0.00112	0.00281	CcSEcCtD
Promethazine—Hallucination—Lisinopril—systemic scleroderma	0.00111	0.00279	CcSEcCtD
Promethazine—Decreased appetite—Mometasone—systemic scleroderma	0.00111	0.00278	CcSEcCtD
Promethazine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.0011	0.00278	CcSEcCtD
Promethazine—Thrombophlebitis—Prednisone—systemic scleroderma	0.0011	0.00278	CcSEcCtD
Promethazine—Shock—Captopril—systemic scleroderma	0.0011	0.00277	CcSEcCtD
Promethazine—Fatigue—Mometasone—systemic scleroderma	0.0011	0.00276	CcSEcCtD
Promethazine—Thrombocytopenia—Captopril—systemic scleroderma	0.00109	0.00275	CcSEcCtD
Promethazine—Tachycardia—Captopril—systemic scleroderma	0.00109	0.00274	CcSEcCtD
Promethazine—CYP2B6—lung—systemic scleroderma	0.00109	0.00686	CbGeAlD
Promethazine—Pain—Mometasone—systemic scleroderma	0.00109	0.00274	CcSEcCtD
Promethazine—Muscle spasms—Leflunomide—systemic scleroderma	0.00108	0.00273	CcSEcCtD
Promethazine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00273	CcSEcCtD
Promethazine—Leukopenia—Azathioprine—systemic scleroderma	0.00107	0.00269	CcSEcCtD
Promethazine—HTR2A—digestive system—systemic scleroderma	0.00106	0.0067	CbGeAlD
Promethazine—HRH1—lung—systemic scleroderma	0.00106	0.0067	CbGeAlD
Promethazine—Vision blurred—Leflunomide—systemic scleroderma	0.00106	0.00268	CcSEcCtD
Promethazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00267	CcSEcCtD
Promethazine—Asthenia—Pentoxifylline—systemic scleroderma	0.00106	0.00266	CcSEcCtD
Promethazine—Tension—Mycophenolic acid—systemic scleroderma	0.00106	0.00266	CcSEcCtD
Promethazine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00105	0.00263	CcSEcCtD
Promethazine—Hypotension—Captopril—systemic scleroderma	0.00104	0.00263	CcSEcCtD
Promethazine—Pruritus—Pentoxifylline—systemic scleroderma	0.00104	0.00263	CcSEcCtD
Promethazine—Tinnitus—Lisinopril—systemic scleroderma	0.00104	0.00261	CcSEcCtD
Promethazine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00103	0.0026	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00103	0.0026	CcSEcCtD
Promethazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00101	0.00255	CcSEcCtD
Promethazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00255	CcSEcCtD
Promethazine—HTR2A—tendon—systemic scleroderma	0.00101	0.00637	CbGeAlD
Promethazine—Insomnia—Captopril—systemic scleroderma	0.00101	0.00254	CcSEcCtD
Promethazine—Leukopenia—Leflunomide—systemic scleroderma	0.00101	0.00254	CcSEcCtD
Promethazine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00101	0.00254	CcSEcCtD
Promethazine—Tremor—Mycophenolic acid—systemic scleroderma	0.00101	0.00254	CcSEcCtD
Promethazine—Coma—Methotrexate—systemic scleroderma	0.00101	0.00253	CcSEcCtD
Promethazine—Palpitations—Leflunomide—systemic scleroderma	0.000997	0.00251	CcSEcCtD
Promethazine—Arrhythmia—Lisinopril—systemic scleroderma	0.000995	0.0025	CcSEcCtD
Promethazine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000993	0.0025	CcSEcCtD
Promethazine—Somnolence—Captopril—systemic scleroderma	0.000993	0.0025	CcSEcCtD
Promethazine—Agitation—Mycophenolic acid—systemic scleroderma	0.000989	0.00249	CcSEcCtD
Promethazine—Dyspepsia—Captopril—systemic scleroderma	0.000983	0.00248	CcSEcCtD
Promethazine—Dizziness—Pentoxifylline—systemic scleroderma	0.000975	0.00245	CcSEcCtD
Promethazine—Decreased appetite—Captopril—systemic scleroderma	0.000971	0.00244	CcSEcCtD
Promethazine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000971	0.00244	CcSEcCtD
Promethazine—Erythema—Lisinopril—systemic scleroderma	0.000969	0.00244	CcSEcCtD
Promethazine—CYP2D6—digestive system—systemic scleroderma	0.000969	0.0061	CbGeAlD
Promethazine—Syncope—Mycophenolic acid—systemic scleroderma	0.000965	0.00243	CcSEcCtD
Promethazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000963	0.00243	CcSEcCtD
Promethazine—Fatigue—Captopril—systemic scleroderma	0.000963	0.00242	CcSEcCtD
Promethazine—Anxiety—Leflunomide—systemic scleroderma	0.000957	0.00241	CcSEcCtD
Promethazine—Constipation—Captopril—systemic scleroderma	0.000955	0.0024	CcSEcCtD
Promethazine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000954	0.0024	CcSEcCtD
Promethazine—Tension—Lisinopril—systemic scleroderma	0.000951	0.00239	CcSEcCtD
Promethazine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000951	0.00239	CcSEcCtD
Promethazine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000946	0.00238	CcSEcCtD
Promethazine—Nervousness—Lisinopril—systemic scleroderma	0.000941	0.00237	CcSEcCtD
Promethazine—Dry mouth—Leflunomide—systemic scleroderma	0.000939	0.00236	CcSEcCtD
Promethazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000932	0.00235	CcSEcCtD
Promethazine—Muscle spasms—Lisinopril—systemic scleroderma	0.000932	0.00235	CcSEcCtD
Promethazine—Rash—Pentoxifylline—systemic scleroderma	0.000929	0.00234	CcSEcCtD
Promethazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000928	0.00234	CcSEcCtD
Promethazine—Headache—Pentoxifylline—systemic scleroderma	0.000923	0.00232	CcSEcCtD
Promethazine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000923	0.00232	CcSEcCtD
Promethazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000921	0.00232	CcSEcCtD
Promethazine—Feeling abnormal—Captopril—systemic scleroderma	0.00092	0.00232	CcSEcCtD
Promethazine—Vision blurred—Lisinopril—systemic scleroderma	0.000913	0.0023	CcSEcCtD
Promethazine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000913	0.0023	CcSEcCtD
Promethazine—Asthenia—Mometasone—systemic scleroderma	0.000912	0.0023	CcSEcCtD
Promethazine—Irritability—Prednisone—systemic scleroderma	0.000912	0.0023	CcSEcCtD
Promethazine—Hypotension—Azathioprine—systemic scleroderma	0.000911	0.00229	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00091	0.00229	CcSEcCtD
Promethazine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00229	CcSEcCtD
Promethazine—Tremor—Lisinopril—systemic scleroderma	0.000908	0.00229	CcSEcCtD
Promethazine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000901	0.00227	CcSEcCtD
Promethazine—Pruritus—Mometasone—systemic scleroderma	0.0009	0.00227	CcSEcCtD
Promethazine—Tachycardia—Leflunomide—systemic scleroderma	0.000898	0.00226	CcSEcCtD
Promethazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000896	0.00226	CcSEcCtD
Promethazine—HTR2A—lung—systemic scleroderma	0.000888	0.00559	CbGeAlD
Promethazine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000885	0.00223	CcSEcCtD
Promethazine—Oedema—Mycophenolic acid—systemic scleroderma	0.000878	0.00221	CcSEcCtD
Promethazine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000871	0.00219	CcSEcCtD
Promethazine—Diarrhoea—Mometasone—systemic scleroderma	0.00087	0.00219	CcSEcCtD
Promethazine—Syncope—Lisinopril—systemic scleroderma	0.000869	0.00219	CcSEcCtD
Promethazine—Leukopenia—Lisinopril—systemic scleroderma	0.000868	0.00218	CcSEcCtD
Promethazine—Shock—Mycophenolic acid—systemic scleroderma	0.000864	0.00218	CcSEcCtD
Promethazine—Hypotension—Leflunomide—systemic scleroderma	0.00086	0.00217	CcSEcCtD
Promethazine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00086	0.00216	CcSEcCtD
Promethazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000857	0.00216	CcSEcCtD
Promethazine—Palpitations—Lisinopril—systemic scleroderma	0.000857	0.00216	CcSEcCtD
Promethazine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000852	0.00214	CcSEcCtD
Promethazine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000833	0.0021	CcSEcCtD
Promethazine—Insomnia—Leflunomide—systemic scleroderma	0.000833	0.0021	CcSEcCtD
Promethazine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000825	0.00208	CcSEcCtD
Promethazine—Anxiety—Lisinopril—systemic scleroderma	0.000822	0.00207	CcSEcCtD
Promethazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000821	0.00207	CcSEcCtD
Promethazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000816	0.00206	CcSEcCtD
Promethazine—Dyspepsia—Leflunomide—systemic scleroderma	0.00081	0.00204	CcSEcCtD
Promethazine—Dry mouth—Lisinopril—systemic scleroderma	0.000807	0.00203	CcSEcCtD
Promethazine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000803	0.00202	CcSEcCtD
Promethazine—Rash—Mometasone—systemic scleroderma	0.000802	0.00202	CcSEcCtD
Promethazine—Asthenia—Captopril—systemic scleroderma	0.000801	0.00202	CcSEcCtD
Promethazine—Dermatitis—Mometasone—systemic scleroderma	0.000801	0.00202	CcSEcCtD
Promethazine—Decreased appetite—Leflunomide—systemic scleroderma	0.0008	0.00201	CcSEcCtD
Promethazine—Confusional state—Lisinopril—systemic scleroderma	0.000798	0.00201	CcSEcCtD
Promethazine—Headache—Mometasone—systemic scleroderma	0.000797	0.00201	CcSEcCtD
Promethazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000796	0.002	CcSEcCtD
Promethazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000794	0.002	CcSEcCtD
Promethazine—Fatigue—Leflunomide—systemic scleroderma	0.000794	0.002	CcSEcCtD
Promethazine—Oedema—Lisinopril—systemic scleroderma	0.000791	0.00199	CcSEcCtD
Promethazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000791	0.00199	CcSEcCtD
Promethazine—Pruritus—Captopril—systemic scleroderma	0.00079	0.00199	CcSEcCtD
Promethazine—Pain—Leflunomide—systemic scleroderma	0.000787	0.00198	CcSEcCtD
Promethazine—Constipation—Leflunomide—systemic scleroderma	0.000787	0.00198	CcSEcCtD
Promethazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000781	0.00197	CcSEcCtD
Promethazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00196	CcSEcCtD
Promethazine—Shock—Lisinopril—systemic scleroderma	0.000778	0.00196	CcSEcCtD
Promethazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000774	0.00195	CcSEcCtD
Promethazine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000773	0.00195	CcSEcCtD
Promethazine—Tachycardia—Lisinopril—systemic scleroderma	0.000772	0.00194	CcSEcCtD
Promethazine—Diarrhoea—Captopril—systemic scleroderma	0.000764	0.00192	CcSEcCtD
Promethazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000763	0.00192	CcSEcCtD
Promethazine—Irritability—Methotrexate—systemic scleroderma	0.000762	0.00192	CcSEcCtD
Promethazine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000762	0.00192	CcSEcCtD
Promethazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00191	CcSEcCtD
Promethazine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000759	0.00191	CcSEcCtD
Promethazine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000757	0.00191	CcSEcCtD
Promethazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000751	0.00189	CcSEcCtD
Promethazine—Pain—Mycophenolic acid—systemic scleroderma	0.000751	0.00189	CcSEcCtD
Promethazine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00189	CcSEcCtD
Promethazine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000746	0.00188	CcSEcCtD
Promethazine—Hypotension—Lisinopril—systemic scleroderma	0.000739	0.00186	CcSEcCtD
Promethazine—Dizziness—Captopril—systemic scleroderma	0.000739	0.00186	CcSEcCtD
Promethazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000736	0.00185	CcSEcCtD
Promethazine—Depression—Prednisone—systemic scleroderma	0.000734	0.00185	CcSEcCtD
Promethazine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000724	0.00182	CcSEcCtD
Promethazine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00181	CcSEcCtD
Promethazine—Insomnia—Lisinopril—systemic scleroderma	0.000715	0.0018	CcSEcCtD
Promethazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00178	CcSEcCtD
Promethazine—Rash—Captopril—systemic scleroderma	0.000704	0.00177	CcSEcCtD
Promethazine—Dermatitis—Captopril—systemic scleroderma	0.000704	0.00177	CcSEcCtD
Promethazine—Somnolence—Lisinopril—systemic scleroderma	0.000703	0.00177	CcSEcCtD
Promethazine—Headache—Captopril—systemic scleroderma	0.0007	0.00176	CcSEcCtD
Promethazine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000699	0.00176	CcSEcCtD
Promethazine—ABCB1—digestive system—systemic scleroderma	0.000697	0.00439	CbGeAlD
Promethazine—Dyspepsia—Lisinopril—systemic scleroderma	0.000696	0.00175	CcSEcCtD
Promethazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00174	CcSEcCtD
Promethazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00174	CcSEcCtD
Promethazine—Asthma—Methotrexate—systemic scleroderma	0.00069	0.00174	CcSEcCtD
Promethazine—Decreased appetite—Lisinopril—systemic scleroderma	0.000688	0.00173	CcSEcCtD
Promethazine—Fatigue—Lisinopril—systemic scleroderma	0.000682	0.00172	CcSEcCtD
Promethazine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00172	CcSEcCtD
Promethazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000679	0.00171	CcSEcCtD
Promethazine—Pain—Lisinopril—systemic scleroderma	0.000676	0.0017	CcSEcCtD
Promethazine—Constipation—Lisinopril—systemic scleroderma	0.000676	0.0017	CcSEcCtD
Promethazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000676	0.0017	CcSEcCtD
Promethazine—Bradycardia—Prednisone—systemic scleroderma	0.000673	0.00169	CcSEcCtD
Promethazine—Diarrhoea—Azathioprine—systemic scleroderma	0.000667	0.00168	CcSEcCtD
Promethazine—Asthenia—Leflunomide—systemic scleroderma	0.00066	0.00166	CcSEcCtD
Promethazine—Hallucination—Prednisone—systemic scleroderma	0.000658	0.00166	CcSEcCtD
Promethazine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000652	0.00164	CcSEcCtD
Promethazine—Pruritus—Leflunomide—systemic scleroderma	0.000651	0.00164	CcSEcCtD
Promethazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000648	0.00163	CcSEcCtD
Promethazine—Dizziness—Azathioprine—systemic scleroderma	0.000645	0.00162	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00063	0.00159	CcSEcCtD
Promethazine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00063	0.00159	CcSEcCtD
Promethazine—Diarrhoea—Leflunomide—systemic scleroderma	0.00063	0.00159	CcSEcCtD
Promethazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00158	CcSEcCtD
Promethazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000621	0.00156	CcSEcCtD
Promethazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000616	0.00155	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—systemic scleroderma	0.000616	0.00155	CcSEcCtD
Promethazine—Rash—Azathioprine—systemic scleroderma	0.000615	0.00155	CcSEcCtD
Promethazine—Dermatitis—Azathioprine—systemic scleroderma	0.000614	0.00155	CcSEcCtD
Promethazine—Depression—Methotrexate—systemic scleroderma	0.000614	0.00155	CcSEcCtD
Promethazine—Headache—Azathioprine—systemic scleroderma	0.000611	0.00154	CcSEcCtD
Promethazine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00061	0.00154	CcSEcCtD
Promethazine—Dizziness—Leflunomide—systemic scleroderma	0.000609	0.00153	CcSEcCtD
Promethazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00152	CcSEcCtD
Promethazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000601	0.00151	CcSEcCtD
Promethazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00149	CcSEcCtD
Promethazine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00149	CcSEcCtD
Promethazine—Arrhythmia—Prednisone—systemic scleroderma	0.000591	0.00149	CcSEcCtD
Promethazine—ABCB1—lung—systemic scleroderma	0.000582	0.00367	CbGeAlD
Promethazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000581	0.00146	CcSEcCtD
Promethazine—Rash—Leflunomide—systemic scleroderma	0.00058	0.00146	CcSEcCtD
Promethazine—Dermatitis—Leflunomide—systemic scleroderma	0.00058	0.00146	CcSEcCtD
Promethazine—Headache—Leflunomide—systemic scleroderma	0.000577	0.00145	CcSEcCtD
Promethazine—Erythema—Prednisone—systemic scleroderma	0.000576	0.00145	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000574	0.00145	CcSEcCtD
Promethazine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000571	0.00144	CcSEcCtD
Promethazine—Asthenia—Lisinopril—systemic scleroderma	0.000568	0.00143	CcSEcCtD
Promethazine—Pruritus—Lisinopril—systemic scleroderma	0.00056	0.00141	CcSEcCtD
Promethazine—Rash—Mycophenolic acid—systemic scleroderma	0.000554	0.00139	CcSEcCtD
Promethazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000553	0.00139	CcSEcCtD
Promethazine—Headache—Mycophenolic acid—systemic scleroderma	0.00055	0.00139	CcSEcCtD
Promethazine—Vision blurred—Prednisone—systemic scleroderma	0.000542	0.00137	CcSEcCtD
Promethazine—Diarrhoea—Lisinopril—systemic scleroderma	0.000541	0.00136	CcSEcCtD
Promethazine—Agitation—Prednisone—systemic scleroderma	0.000529	0.00133	CcSEcCtD
Promethazine—Dizziness—Lisinopril—systemic scleroderma	0.000523	0.00132	CcSEcCtD
Promethazine—Syncope—Prednisone—systemic scleroderma	0.000516	0.0013	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—systemic scleroderma	0.000515	0.0013	CcSEcCtD
Promethazine—Loss of consciousness—Prednisone—systemic scleroderma	0.000506	0.00127	CcSEcCtD
Promethazine—Rash—Lisinopril—systemic scleroderma	0.000499	0.00126	CcSEcCtD
Promethazine—Convulsion—Prednisone—systemic scleroderma	0.000499	0.00126	CcSEcCtD
Promethazine—Dermatitis—Lisinopril—systemic scleroderma	0.000498	0.00125	CcSEcCtD
Promethazine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000497	0.00125	CcSEcCtD
Promethazine—Headache—Lisinopril—systemic scleroderma	0.000496	0.00125	CcSEcCtD
Promethazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00123	CcSEcCtD
Promethazine—Anxiety—Prednisone—systemic scleroderma	0.000488	0.00123	CcSEcCtD
Promethazine—Erythema—Methotrexate—systemic scleroderma	0.000481	0.00121	CcSEcCtD
Promethazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00119	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00047	0.00118	CcSEcCtD
Promethazine—Oedema—Prednisone—systemic scleroderma	0.00047	0.00118	CcSEcCtD
Promethazine—Shock—Prednisone—systemic scleroderma	0.000462	0.00116	CcSEcCtD
Promethazine—Tachycardia—Prednisone—systemic scleroderma	0.000459	0.00115	CcSEcCtD
Promethazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000458	0.00115	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—systemic scleroderma	0.000453	0.00114	CcSEcCtD
Promethazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000437	0.0011	CcSEcCtD
Promethazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000437	0.0011	CcSEcCtD
Promethazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00109	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—systemic scleroderma	0.000431	0.00108	CcSEcCtD
Promethazine—Insomnia—Prednisone—systemic scleroderma	0.000425	0.00107	CcSEcCtD
Promethazine—Convulsion—Methotrexate—systemic scleroderma	0.000417	0.00105	CcSEcCtD
Promethazine—Dyspepsia—Prednisone—systemic scleroderma	0.000414	0.00104	CcSEcCtD
Promethazine—Decreased appetite—Prednisone—systemic scleroderma	0.000408	0.00103	CcSEcCtD
Promethazine—Fatigue—Prednisone—systemic scleroderma	0.000405	0.00102	CcSEcCtD
Promethazine—Constipation—Prednisone—systemic scleroderma	0.000402	0.00101	CcSEcCtD
Promethazine—Confusional state—Methotrexate—systemic scleroderma	0.000396	0.000997	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000393	0.000989	CcSEcCtD
Promethazine—Feeling abnormal—Prednisone—systemic scleroderma	0.000387	0.000975	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000384	0.000968	CcSEcCtD
Promethazine—Hypotension—Methotrexate—systemic scleroderma	0.000367	0.000924	CcSEcCtD
Promethazine—Insomnia—Methotrexate—systemic scleroderma	0.000355	0.000894	CcSEcCtD
Promethazine—Somnolence—Methotrexate—systemic scleroderma	0.000349	0.000879	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—systemic scleroderma	0.000346	0.00087	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000341	0.000859	CcSEcCtD
Promethazine—Fatigue—Methotrexate—systemic scleroderma	0.000338	0.000852	CcSEcCtD
Promethazine—Asthenia—Prednisone—systemic scleroderma	0.000337	0.000849	CcSEcCtD
Promethazine—Pain—Methotrexate—systemic scleroderma	0.000336	0.000845	CcSEcCtD
Promethazine—Pruritus—Prednisone—systemic scleroderma	0.000332	0.000837	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000324	0.000815	CcSEcCtD
Promethazine—Diarrhoea—Prednisone—systemic scleroderma	0.000321	0.000809	CcSEcCtD
Promethazine—Dizziness—Prednisone—systemic scleroderma	0.000311	0.000782	CcSEcCtD
Promethazine—Rash—Prednisone—systemic scleroderma	0.000296	0.000746	CcSEcCtD
Promethazine—Dermatitis—Prednisone—systemic scleroderma	0.000296	0.000745	CcSEcCtD
Promethazine—Headache—Prednisone—systemic scleroderma	0.000294	0.000741	CcSEcCtD
Promethazine—Asthenia—Methotrexate—systemic scleroderma	0.000282	0.000709	CcSEcCtD
Promethazine—Pruritus—Methotrexate—systemic scleroderma	0.000278	0.000699	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000269	0.000676	CcSEcCtD
Promethazine—Dizziness—Methotrexate—systemic scleroderma	0.00026	0.000654	CcSEcCtD
Promethazine—Rash—Methotrexate—systemic scleroderma	0.000248	0.000623	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—systemic scleroderma	0.000247	0.000623	CcSEcCtD
Promethazine—Headache—Methotrexate—systemic scleroderma	0.000246	0.000619	CcSEcCtD
Promethazine—CHRM4—Signaling Pathways—HSPG2—systemic scleroderma	6.09e-05	0.000923	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	6.02e-05	0.000912	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	5.96e-05	0.000902	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	5.96e-05	0.000902	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFBI—systemic scleroderma	5.94e-05	0.0009	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFBI—systemic scleroderma	5.94e-05	0.0009	CbGpPWpGaD
Promethazine—CHRM5—GPCR downstream signaling—EDN1—systemic scleroderma	5.89e-05	0.000892	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CSK—systemic scleroderma	5.89e-05	0.000892	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—EDN1—systemic scleroderma	5.88e-05	0.000891	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HSPG2—systemic scleroderma	5.84e-05	0.000884	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	5.82e-05	0.000882	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	5.82e-05	0.000882	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SMAD7—systemic scleroderma	5.76e-05	0.000872	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SMAD7—systemic scleroderma	5.66e-05	0.000858	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SMAD7—systemic scleroderma	5.65e-05	0.000856	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CSK—systemic scleroderma	5.64e-05	0.000854	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SMAD7—systemic scleroderma	5.63e-05	0.000853	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SMAD7—systemic scleroderma	5.62e-05	0.00085	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—EDN1—systemic scleroderma	5.59e-05	0.000846	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SMAD7—systemic scleroderma	5.56e-05	0.000842	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SMAD7—systemic scleroderma	5.55e-05	0.00084	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—EDN1—systemic scleroderma	5.35e-05	0.00081	CbGpPWpGaD
Promethazine—DRD2—GPCR ligand binding—CCL2—systemic scleroderma	5.13e-05	0.000776	CbGpPWpGaD
Promethazine—CALM3—Immune System—CSK—systemic scleroderma	5.12e-05	0.000776	CbGpPWpGaD
Promethazine—HTR2A—GPCR ligand binding—CCL2—systemic scleroderma	5.04e-05	0.000764	CbGpPWpGaD
Promethazine—CALM3—Immune System—IRF5—systemic scleroderma	5.04e-05	0.000763	CbGpPWpGaD
Promethazine—HRH1—GPCR ligand binding—CCL2—systemic scleroderma	5.03e-05	0.000762	CbGpPWpGaD
Promethazine—CHRM1—GPCR ligand binding—CCL2—systemic scleroderma	5.02e-05	0.00076	CbGpPWpGaD
Promethazine—CHRM3—GPCR ligand binding—CCL2—systemic scleroderma	5e-05	0.000757	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.96e-05	0.000751	CbGpPWpGaD
Promethazine—CALM2—Immune System—CSK—systemic scleroderma	4.96e-05	0.000751	CbGpPWpGaD
Promethazine—CALM1—Immune System—CSK—systemic scleroderma	4.96e-05	0.000751	CbGpPWpGaD
Promethazine—CHRM2—GPCR ligand binding—CCL2—systemic scleroderma	4.95e-05	0.00075	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.94e-05	0.000748	CbGpPWpGaD
Promethazine—ADRA1A—GPCR ligand binding—CCL2—systemic scleroderma	4.94e-05	0.000748	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—HSPG2—systemic scleroderma	4.9e-05	0.000742	CbGpPWpGaD
Promethazine—CALM3—Disease—HSPG2—systemic scleroderma	4.9e-05	0.000742	CbGpPWpGaD
Promethazine—CALM2—Immune System—IRF5—systemic scleroderma	4.88e-05	0.000738	CbGpPWpGaD
Promethazine—CALM1—Immune System—IRF5—systemic scleroderma	4.88e-05	0.000738	CbGpPWpGaD
Promethazine—CALM3—Immune System—ITGAM—systemic scleroderma	4.82e-05	0.00073	CbGpPWpGaD
Promethazine—CALM3—Immune System—IRF8—systemic scleroderma	4.82e-05	0.00073	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD247—systemic scleroderma	4.82e-05	0.00073	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.79e-05	0.000726	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.79e-05	0.000726	CbGpPWpGaD
Promethazine—CALM2—Disease—HSPG2—systemic scleroderma	4.74e-05	0.000718	CbGpPWpGaD
Promethazine—CALM1—Disease—HSPG2—systemic scleroderma	4.74e-05	0.000718	CbGpPWpGaD
Promethazine—CALM3—Disease—CSK—systemic scleroderma	4.73e-05	0.000716	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	4.7e-05	0.000712	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	4.68e-05	0.000709	CbGpPWpGaD
Promethazine—CALM1—Immune System—IRF8—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM2—Immune System—IRF8—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD247—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD247—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM2—Immune System—ITGAM—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM1—Immune System—ITGAM—systemic scleroderma	4.66e-05	0.000706	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—MMP1—systemic scleroderma	4.6e-05	0.000697	CbGpPWpGaD
Promethazine—CALM2—Disease—CSK—systemic scleroderma	4.58e-05	0.000693	CbGpPWpGaD
Promethazine—CALM1—Disease—CSK—systemic scleroderma	4.58e-05	0.000693	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	4.55e-05	0.000689	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	4.55e-05	0.000689	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	4.53e-05	0.000686	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	4.53e-05	0.000686	CbGpPWpGaD
Promethazine—CALM3—Immune System—TNFAIP3—systemic scleroderma	4.51e-05	0.000683	CbGpPWpGaD
Promethazine—CALM3—Immune System—BLK—systemic scleroderma	4.46e-05	0.000675	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—MMP1—systemic scleroderma	4.45e-05	0.000674	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—MMP1—systemic scleroderma	4.45e-05	0.000674	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—RHOB—systemic scleroderma	4.45e-05	0.000674	CbGpPWpGaD
Promethazine—CALM3—Disease—CD247—systemic scleroderma	4.45e-05	0.000674	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—RHOB—systemic scleroderma	4.38e-05	0.000664	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—RHOB—systemic scleroderma	4.37e-05	0.000662	CbGpPWpGaD
Promethazine—CALM2—Immune System—TNFAIP3—systemic scleroderma	4.36e-05	0.000661	CbGpPWpGaD
Promethazine—CALM1—Immune System—TNFAIP3—systemic scleroderma	4.36e-05	0.000661	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—RHOB—systemic scleroderma	4.36e-05	0.00066	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—RHOB—systemic scleroderma	4.34e-05	0.000658	CbGpPWpGaD
Promethazine—CALM2—Immune System—BLK—systemic scleroderma	4.31e-05	0.000653	CbGpPWpGaD
Promethazine—CALM1—Immune System—BLK—systemic scleroderma	4.31e-05	0.000653	CbGpPWpGaD
Promethazine—CALM2—Disease—CD247—systemic scleroderma	4.3e-05	0.000652	CbGpPWpGaD
Promethazine—CALM1—Disease—CD247—systemic scleroderma	4.3e-05	0.000652	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—RHOB—systemic scleroderma	4.3e-05	0.000652	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	4.29e-05	0.00065	CbGpPWpGaD
Promethazine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	4.28e-05	0.000648	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	4.24e-05	0.000642	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—HSPG2—systemic scleroderma	4.21e-05	0.000638	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	4.2e-05	0.000636	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	4.17e-05	0.000632	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	4.16e-05	0.00063	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—EDN1—systemic scleroderma	4.15e-05	0.000628	CbGpPWpGaD
Promethazine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	4.14e-05	0.000627	CbGpPWpGaD
Promethazine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	4.14e-05	0.000627	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—EDN1—systemic scleroderma	4.13e-05	0.000626	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	4.13e-05	0.000626	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	4.12e-05	0.000624	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HSPG2—systemic scleroderma	4.11e-05	0.000622	CbGpPWpGaD
Promethazine—CALM3—Metabolism—HSPG2—systemic scleroderma	4.1e-05	0.000621	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HSPG2—systemic scleroderma	4.1e-05	0.00062	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—EDN1—systemic scleroderma	4.09e-05	0.00062	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	4.08e-05	0.000618	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HSPG2—systemic scleroderma	4.06e-05	0.000614	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CSK—systemic scleroderma	4.06e-05	0.000614	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	4.05e-05	0.000613	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—CCL2—systemic scleroderma	4.02e-05	0.000609	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CSK—systemic scleroderma	3.99e-05	0.000604	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CSK—systemic scleroderma	3.98e-05	0.000603	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CSK—systemic scleroderma	3.97e-05	0.000601	CbGpPWpGaD
Promethazine—CALM1—Metabolism—HSPG2—systemic scleroderma	3.97e-05	0.000601	CbGpPWpGaD
Promethazine—CALM2—Metabolism—HSPG2—systemic scleroderma	3.97e-05	0.000601	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CSK—systemic scleroderma	3.96e-05	0.000599	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CSK—systemic scleroderma	3.92e-05	0.000593	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	3.91e-05	0.000592	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	3.85e-05	0.000583	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—CCL2—systemic scleroderma	3.82e-05	0.000578	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	3.79e-05	0.000574	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	3.78e-05	0.000572	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—EDN1—systemic scleroderma	3.77e-05	0.00057	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—EDN1—systemic scleroderma	3.75e-05	0.000569	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—EDN1—systemic scleroderma	3.72e-05	0.000563	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—CTGF—systemic scleroderma	3.71e-05	0.000562	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	3.71e-05	0.000562	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—CCL2—systemic scleroderma	3.66e-05	0.000554	CbGpPWpGaD
Promethazine—CALM3—Immune System—CTLA4—systemic scleroderma	3.65e-05	0.000553	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.65e-05	0.000552	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	3.64e-05	0.000551	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—NOS3—systemic scleroderma	3.58e-05	0.000543	CbGpPWpGaD
Promethazine—CALM2—Immune System—CTLA4—systemic scleroderma	3.53e-05	0.000535	CbGpPWpGaD
Promethazine—CALM1—Immune System—CTLA4—systemic scleroderma	3.53e-05	0.000535	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	3.52e-05	0.000533	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	3.52e-05	0.000533	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	3.43e-05	0.000519	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—NOS3—systemic scleroderma	3.34e-05	0.000505	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	3.32e-05	0.000502	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	3.32e-05	0.000502	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CSK—systemic scleroderma	3.31e-05	0.000502	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EDN1—systemic scleroderma	3.3e-05	0.0005	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—NOS3—systemic scleroderma	3.23e-05	0.000489	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—NOS3—systemic scleroderma	3.23e-05	0.000489	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CSK—systemic scleroderma	3.2e-05	0.000485	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CSK—systemic scleroderma	3.2e-05	0.000485	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—CTGF—systemic scleroderma	3.19e-05	0.000484	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EDN1—systemic scleroderma	3.16e-05	0.000479	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	3.14e-05	0.000476	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—HSPG2—systemic scleroderma	3.11e-05	0.000471	CbGpPWpGaD
Promethazine—CALM3—Metabolism—CTGF—systemic scleroderma	3.11e-05	0.000471	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	3.04e-05	0.000461	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	3.04e-05	0.000461	CbGpPWpGaD
Promethazine—CALM1—Metabolism—CTGF—systemic scleroderma	3.01e-05	0.000455	CbGpPWpGaD
Promethazine—CALM2—Metabolism—CTGF—systemic scleroderma	3.01e-05	0.000455	CbGpPWpGaD
Promethazine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	3.01e-05	0.000455	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.93e-05	0.000444	CbGpPWpGaD
Promethazine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	2.91e-05	0.00044	CbGpPWpGaD
Promethazine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	2.91e-05	0.00044	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	2.9e-05	0.00044	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MMP9—systemic scleroderma	2.88e-05	0.000435	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1A—systemic scleroderma	2.86e-05	0.000432	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD40LG—systemic scleroderma	2.84e-05	0.00043	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1A—systemic scleroderma	2.76e-05	0.000418	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1A—systemic scleroderma	2.76e-05	0.000418	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD40LG—systemic scleroderma	2.75e-05	0.000416	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD40LG—systemic scleroderma	2.75e-05	0.000416	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	2.63e-05	0.000398	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	2.59e-05	0.000392	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	2.58e-05	0.000391	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—CCL2—systemic scleroderma	2.57e-05	0.00039	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—CCL2—systemic scleroderma	2.57e-05	0.000389	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—CCL2—systemic scleroderma	2.54e-05	0.000385	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	2.53e-05	0.000384	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TGFB1—systemic scleroderma	2.37e-05	0.000359	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CTGF—systemic scleroderma	2.36e-05	0.000357	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EDN1—systemic scleroderma	2.27e-05	0.000344	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CCL2—systemic scleroderma	2.26e-05	0.000342	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	2.24e-05	0.000339	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	2.23e-05	0.000338	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EDN1—systemic scleroderma	2.22e-05	0.000337	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CTGF—systemic scleroderma	2.22e-05	0.000336	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EDN1—systemic scleroderma	2.22e-05	0.000336	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TGFB1—systemic scleroderma	2.21e-05	0.000334	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CTGF—systemic scleroderma	2.2e-05	0.000333	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EDN1—systemic scleroderma	2.2e-05	0.000333	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	2.19e-05	0.000332	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CCL2—systemic scleroderma	2.16e-05	0.000327	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	2.15e-05	0.000325	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TGFB1—systemic scleroderma	2.13e-05	0.000323	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TGFB1—systemic scleroderma	2.13e-05	0.000323	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	2.08e-05	0.000315	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	2.08e-05	0.000315	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—NOS3—systemic scleroderma	2.01e-05	0.000305	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—NOS3—systemic scleroderma	1.93e-05	0.000292	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	1.86e-05	0.000281	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	1.8e-05	0.000272	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	1.8e-05	0.000272	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—NOS3—systemic scleroderma	1.62e-05	0.000245	CbGpPWpGaD
Promethazine—CALM3—Disease—NOS3—systemic scleroderma	1.62e-05	0.000245	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP9—systemic scleroderma	1.61e-05	0.000244	CbGpPWpGaD
Promethazine—CALM1—Disease—NOS3—systemic scleroderma	1.56e-05	0.000237	CbGpPWpGaD
Promethazine—CALM2—Disease—NOS3—systemic scleroderma	1.56e-05	0.000237	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCL2—systemic scleroderma	1.55e-05	0.000235	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP9—systemic scleroderma	1.54e-05	0.000234	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	1.53e-05	0.000232	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	1.53e-05	0.000231	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCL2—systemic scleroderma	1.52e-05	0.00023	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCL2—systemic scleroderma	1.52e-05	0.00023	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCL2—systemic scleroderma	1.5e-05	0.000227	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	1.5e-05	0.000227	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1B—systemic scleroderma	1.49e-05	0.000226	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1B—systemic scleroderma	1.44e-05	0.000218	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1B—systemic scleroderma	1.44e-05	0.000218	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—NOS3—systemic scleroderma	1.39e-05	0.000211	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NOS3—systemic scleroderma	1.39e-05	0.00021	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	1.36e-05	0.000206	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	1.36e-05	0.000206	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NOS3—systemic scleroderma	1.36e-05	0.000205	CbGpPWpGaD
Promethazine—CALM3—Metabolism—NOS3—systemic scleroderma	1.35e-05	0.000205	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NOS3—systemic scleroderma	1.35e-05	0.000205	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NOS3—systemic scleroderma	1.34e-05	0.000203	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	1.33e-05	0.000202	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TGFB1—systemic scleroderma	1.33e-05	0.000201	CbGpPWpGaD
Promethazine—CALM2—Metabolism—NOS3—systemic scleroderma	1.31e-05	0.000198	CbGpPWpGaD
Promethazine—CALM1—Metabolism—NOS3—systemic scleroderma	1.31e-05	0.000198	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TGFB1—systemic scleroderma	1.27e-05	0.000193	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	1.27e-05	0.000192	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	1.23e-05	0.000186	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	1.23e-05	0.000186	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	1.13e-05	0.000171	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—systemic scleroderma	1.11e-05	0.000168	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	1.09e-05	0.000166	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	1.09e-05	0.000166	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	1.09e-05	0.000166	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	1.09e-05	0.000165	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—systemic scleroderma	1.09e-05	0.000165	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—systemic scleroderma	1.08e-05	0.000164	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000163	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000162	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—systemic scleroderma	1.07e-05	0.000162	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—systemic scleroderma	1.03e-05	0.000157	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—systemic scleroderma	1.03e-05	0.000157	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—NOS3—systemic scleroderma	1.03e-05	0.000155	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—NOS3—systemic scleroderma	9.66e-06	0.000146	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—NOS3—systemic scleroderma	9.58e-06	0.000145	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	9.16e-06	0.000139	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	9.08e-06	0.000137	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	9.01e-06	0.000136	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	8.99e-06	0.000136	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—systemic scleroderma	8.96e-06	0.000136	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—systemic scleroderma	8.94e-06	0.000135	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—systemic scleroderma	8.85e-06	0.000134	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	8.82e-06	0.000134	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	8.78e-06	0.000133	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	8.78e-06	0.000133	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	7.48e-06	0.000113	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	7.24e-06	0.00011	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	7.24e-06	0.00011	CbGpPWpGaD
